Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirofumi Shoda

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 18, 2016
[Citrullination and rheumatoid arthritis]Hirofumi Shoda
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 7, 2007
[Rheumatoid arthritis and interleukin-32]Hirofumi Shoda, Keishi Fujio, Kazuhiko Yamamoto
Immunological Medicine|April 3, 2019
New horizons in clinical immunology: applications of induced pluripotent stem cells for the analysis of immune disordersHirofumi Shoda, Bunki Natsumoto, Keishi Fujio
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 1, 2012
[Autoantigen BiP and autoimmune diseases]Hirofumi Shoda, Keishi Fujio, Kazuhiko Yamamoto
Modern Rheumatology Case Reports|December 3, 2020
Successful treatment by mycophenolate mofetil of subacute progressive interstitial lung disease associated with systemic lupus erythematosusNorio Hanata, Hirofumi Shoda, Keishi Fujio
Cells|February 13, 2019
Immune Profiling and Precision Medicine in Systemic Lupus ErythematosusYasuo Nagafuchi, Hirofumi Shoda, Keishi Fujio
Inflammation and Regeneration|October 25, 2023
Investigation of immune-related diseases using patient-derived induced pluripotent stem cellsHirofumi Shoda, Bunki Natsumoto, Keishi Fujio
Rheumatology International|September 29, 2022
Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathyShinji Izuka, Toshihiko Komai, Hirofumi Shoda, et al.
International Journal of Rheumatic Diseases|October 14, 2020
Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseasesRisa Yoshihara, Toshihiko Komai, Hirofumi Shoda, et al.
Rheumatology (Oxford, England)|February 5, 2025
Evaluation of patient-based disease activity score (PDAS) in the Japanese rheumatoid arthritis patient registry (NinJa registry)Hirofumi Shoda, Toshihiro Matsui, Shigeto Tohma, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 18, 2016
[Citrullination and rheumatoid arthritis]Hirofumi Shoda
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 7, 2007
[Rheumatoid arthritis and interleukin-32]Hirofumi Shoda, Keishi Fujio, Kazuhiko Yamamoto
Immunological Medicine|April 3, 2019
New horizons in clinical immunology: applications of induced pluripotent stem cells for the analysis of immune disordersHirofumi Shoda, Bunki Natsumoto, Keishi Fujio
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 1, 2012
[Autoantigen BiP and autoimmune diseases]Hirofumi Shoda, Keishi Fujio, Kazuhiko Yamamoto
Modern Rheumatology Case Reports|December 3, 2020
Successful treatment by mycophenolate mofetil of subacute progressive interstitial lung disease associated with systemic lupus erythematosusNorio Hanata, Hirofumi Shoda, Keishi Fujio
Cells|February 13, 2019
Immune Profiling and Precision Medicine in Systemic Lupus ErythematosusYasuo Nagafuchi, Hirofumi Shoda, Keishi Fujio
Inflammation and Regeneration|October 25, 2023
Investigation of immune-related diseases using patient-derived induced pluripotent stem cellsHirofumi Shoda, Bunki Natsumoto, Keishi Fujio
Rheumatology International|September 29, 2022
Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathyShinji Izuka, Toshihiko Komai, Hirofumi Shoda, et al.
International Journal of Rheumatic Diseases|October 14, 2020
Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseasesRisa Yoshihara, Toshihiko Komai, Hirofumi Shoda, et al.
Rheumatology (Oxford, England)|February 5, 2025
Evaluation of patient-based disease activity score (PDAS) in the Japanese rheumatoid arthritis patient registry (NinJa registry)Hirofumi Shoda, Toshihiro Matsui, Shigeto Tohma, et al.
Pageof 10